Literature DB >> 20212136

Cis lethal genetic interactions attenuate and alter p53 tumorigenesis.

Yuxun Wang1, Weijia Zhang, Lisa Edelmann, Richard D Kolodner, Raju Kucherlapati, Winfried Edelmann.   

Abstract

Rpa1, an essential gene involved in DNA replication and genome maintenance, is syntenic and linked to Trp53 in mice and humans. To study the genetic interaction between Rpa1 and Trp53 in tumorigenesis, we generated compound Rpa1(L230P/+); Trp53(+/-) mutant mice with the mutant alleles in either trans or cis configuration. We demonstrate that the Rpa1(L230P) missense mutation significantly alters the tumor phenotype and spectrum of Trp53 mutant mice by modifying the genetic mechanisms underlying tumorigenesis. Importantly, when the Rpa1(L230P) and Trp53 mutant alleles are in cis, the tumor phenotype is attenuated and altered and loss of heterozygosity (LOH) at the Trp53 wild-type locus is selected against, whereas in the trans configuration, Rpa1(L230P) enhances the Trp53(+/-) tumor phenotype even though Rpa1(L230P) is ultimately lost by LOH. These studies indicate that polymorphic genetic variants in cell essential genes can genetically affect closely linked tumor suppressor loci via allelic phasing, which can result in profound phenotypic variations in tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20212136      PMCID: PMC2851751          DOI: 10.1073/pnas.1001223107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Primed in situ labeling (PRINS) for evaluation of gene deletions in cancer.

Authors:  Sugandhi A Tharapel; Jayarama S Kadandale
Journal:  Am J Med Genet       Date:  2002-01-15

2.  Allele loss on short arm of chromosome 17 in breast cancers.

Authors:  J Mackay; C M Steel; P A Elder; A P Forrest; H J Evans
Journal:  Lancet       Date:  1988-12-17       Impact factor: 79.321

3.  Loss of heterozygosity frequency at the Trp53 locus in p53-deficient (+/-) mouse tumors is carcinogen-and tissue-dependent.

Authors:  J E French; G D Lacks; C Trempus; J K Dunnick; J Foley; J Mahler; R R Tice; R W Tennant
Journal:  Carcinogenesis       Date:  2001-01       Impact factor: 4.944

4.  Mutation analysis of replicative genes encoding the large subunits of DNA polymerase alpha and replication factors A and C in human sporadic colorectal cancers.

Authors:  O Popanda; C Zheng; J R Magdeburg; J Büttner; T Flohr; E Hagmüller; H W Thielmann
Journal:  Int J Cancer       Date:  2000-05-01       Impact factor: 7.396

5.  Epigenetic and genetic loss of Hic1 function accentuates the role of p53 in tumorigenesis.

Authors:  Wenyong Chen; Timothy K Cooper; Cynthia A Zahnow; Michael Overholtzer; Zhiquan Zhao; Marc Ladanyi; Judith E Karp; Nalan Gokgoz; Jay S Wunder; Irene L Andrulis; Arnold J Levine; Joseph L Mankowski; Stephen B Baylin
Journal:  Cancer Cell       Date:  2004-10       Impact factor: 31.743

6.  The presence of p53 mutations in human osteosarcomas correlates with high levels of genomic instability.

Authors:  Michael Overholtzer; Pulivarthi H Rao; Reyna Favis; Xin-Yan Lu; Michael B Elowitz; Francis Barany; Marc Ladanyi; Richard Gorlick; Arnold J Levine
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-12       Impact factor: 11.205

7.  Murine p53 intron sequences 5-8 and their use in polymerase chain reaction/direct sequencing analysis of p53 mutations in CD-1 mouse liver and lung tumors.

Authors:  T L Goodrow; R D Storer; K R Leander; S R Prahalada; M J van Zwieten; M O Bradley
Journal:  Mol Carcinog       Date:  1992       Impact factor: 4.784

8.  Allelic phasing of a mouse chromosome 11 deficiency influences p53 tumorigenicity.

Authors:  Patrick J Biggs; Hannes Vogel; Marijke Sage; Lucy A Martin; Larry A Donehower; Allan Bradley
Journal:  Oncogene       Date:  2003-05-22       Impact factor: 9.867

9.  Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas.

Authors:  S J Baker; E R Fearon; J M Nigro; S R Hamilton; A C Preisinger; J M Jessup; P vanTuinen; D H Ledbetter; D F Barker; Y Nakamura; R White; B Vogelstein
Journal:  Science       Date:  1989-04-14       Impact factor: 47.728

10.  Genetic interactions between Pten and p53 in radiation-induced lymphoma development.

Authors:  Jian-Hua Mao; Di Wu; Jesus Perez-Losada; Hiroki Nagase; Reyno DelRosario; Allan Balmain
Journal:  Oncogene       Date:  2003-11-20       Impact factor: 9.867

View more
  5 in total

1.  A comprehensively molecular haplotype-resolved genome of a European individual.

Authors:  Eun-Kyung Suk; Gayle K McEwen; Jorge Duitama; Katja Nowick; Sabrina Schulz; Stefanie Palczewski; Stefan Schreiber; Dustin T Holloway; Stephen McLaughlin; Heather Peckham; Clarence Lee; Thomas Huebsch; Margret R Hoehe
Journal:  Genome Res       Date:  2011-08-03       Impact factor: 9.043

2.  The MutSβ complex is a modulator of p53-driven tumorigenesis through its functions in both DNA double-strand break repair and mismatch repair.

Authors:  J M M van Oers; Y Edwards; R Chahwan; W Zhang; C Smith; X Pechuan; S Schaetzlein; B Jin; Y Wang; A Bergman; M D Scharff; W Edelmann
Journal:  Oncogene       Date:  2013-09-09       Impact factor: 9.867

3.  Genes essential for cell viability that are linked to tumor suppressor genes play a role in cancer susceptibility.

Authors:  Yuxun Wang; Bin Huang; Lisa Edelmann; Richard D Kolodner; Winfried Edelmann
Journal:  Cell Cycle       Date:  2010-08-09       Impact factor: 4.534

4.  Increased RPA1 gene dosage affects genomic stability potentially contributing to 17p13.3 duplication syndrome.

Authors:  Emily Outwin; Gillian Carpenter; Weimin Bi; Marjorie A Withers; James R Lupski; Mark O'Driscoll
Journal:  PLoS Genet       Date:  2011-08-25       Impact factor: 5.917

5.  Gain-of-function mutations in RPA1 cause a syndrome with short telomeres and somatic genetic rescue.

Authors:  Richa Sharma; Sushree S Sahoo; Masayoshi Honda; Sophie L Granger; Charnise Goodings; Louis Sanchez; Axel Künstner; Hauke Busch; Fabian Beier; Shondra M Pruett-Miller; Marcus B Valentine; Alfonso G Fernandez; Ti-Cheng Chang; Vincent Géli; Dmitri Churikov; Sandrine Hirschi; Victor B Pastor; Melanie Boerries; Melchior Lauten; Charikleia Kelaidi; Megan A Cooper; Sarah Nicholas; Jill A Rosenfeld; Sophia Polychronopoulou; Caroline Kannengiesser; Carole Saintomé; Charlotte M Niemeyer; Patrick Revy; Marc S Wold; Maria Spies; Miriam Erlacher; Stéphane Coulon; Marcin W Wlodarski
Journal:  Blood       Date:  2022-02-17       Impact factor: 22.113

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.